SOM Biotech had the opportunity to present SOM3355 program for Huntington’s disease during the XIII Pharma-Biotech Cooperation Sessions organized by FARMAINDUSTRIA. Barcelona, October 20^th 2015.

For further information please visit medicamentos innovadores.